Back
Verint Systems 10K Form
Sell
28
VRNT
Verint Systems
Last Price:
23.43
Seasonality Move:
6.48%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-06-04 | 10Q | VRNT/Verint Systems Quarterly |
2023-12-06 | 10Q | VRNT/Verint Systems Quarterly |
2023-09-06 | 10Q | VRNT/Verint Systems Quarterly |
2023-06-07 | 10Q | VRNT/Verint Systems Quarterly |
2022-12-07 | 10Q | VRNT/Verint Systems Quarterly |
2022-09-07 | 10Q | VRNT/Verint Systems Quarterly |
Receive VRNT News And Ratings
See the #1 stock for the next 7 days that we like better than VRNT
VRNT Financial Statistics
Sales & Book Value
Annual Sales: | $910.39M |
---|---|
Cash Flow: | $-3.58M |
Price / Cash Flow: | 12.46 |
Annual Sales: | $13.48 |
Price / Book: | 1.83 |
Profitability
EPS (TTM): | 0.67000 |
---|---|
Net Income (TTM): | $62.09M |
Gross Margin: | $633.28M |
Return on Equity: | 4.93% |
Return on Assets: | 2.84% |
Verint Systems Earnings Forecast
Key Verint Systems Financial Ratios
- The Gross Profit Margin over the past 23 years for VRNT is 69.56%.
- The Selling, General & Administrative Expenses for VRNT have been equal to 44.59% of Gross Profit Margin.
- The Research & Development expenses have been 14.70% of Revenue.
- The Interest Expense is 26.77% of Operating Income.
- The Net Earning history of VRNT is 4.24% of Total Revenues.
- Per Share Earnings over the last 23 years have been positive in 13 years.
Verint Systems Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Software |
Sector: | Information Technology |
Current Symbol: | VRNT |
CUSIP: | 92343X |
Website: | verint.com |
Debt
Debt-to-Equity Ratio: | 0.32 |
---|---|
Current Ratio: | 1.41 |
Quick Ratio: | 1.22 |
Price-to-Earnings
Trailing P/E Ratio: | 88.11 |
---|---|
Forward P/E Ratio: | 7.9 |
VRNT Technical Analysis vs Fundamental Analysis
Sell
28
Verint Systems (VRNT)
is a Sell
Is Verint Systems a Buy or a Sell?
-
Verint Systems stock is rated a Sell
The current Verint Systems [VRNT] share price is $23.48. The Score for VRNT is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.